---
course_id: 7-340-ubiquitination-the-proteasome-and-human-disease-fall-2004
layout: course_section
menu:
  leftnav:
    identifier: 43e23b5f2c3d37b2c61c199822754afa
    name: Lecture Notes
    weight: 40
title: Lecture Notes
type: course
uid: 43e23b5f2c3d37b2c61c199822754afa

---

| LEC #          | TOPICS                                              |
| --- | --- |
| 1 | Introduction ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s1ands2)) |
| 2 | Discovery of the Ubiquitin Conjugation System ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s1ands2)) |
| 3 | Protein Degradation in Trafficking Membranes I: Endoplasmic Reticulum Associated Degradation (ERAD) Pathway ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s3)) |
| 4 | Protein Degradation in Trafficking Membranes II: Endocytosis and lysosomal Degradation ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s4)) |
| 5 | Role of Ubiquitination in Transcriptional Regulation ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s5)) |
| 6 | Role of Ubiquitination in Cell Cycle Control and Programmed Cell Death ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s6)) |
| 7 | Ubiquitin-like Proteins ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s7)) |
| 8 | Functions of the Ubiquitin-Proteasome System in the Immune System ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s8)) |
| 9 | Ubiquitin and Cancer ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s9)) |
| 10 | Ubiquitin and Neurodegenerative Diseases: Alzheimer's and Parkinson's Diseases ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s10)) |
| 11 | More Diseases Involving Ubiquitin: Huntington's and Von Hippel-Lindau Disease ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s11)) |
| 12 | Too Much Degradation Can Be as Bad as Not Enough: Cystic Fibrosis and Liddle's Syndrome ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s12)) |
| 13 | Potential Therapeutic Strategies in Ubiquitin-Related Diseases ([PDF]({{< baseurl >}}/sections/lecture-notes/intro_s13)) |
| 14 | Oral Presentations  {{< br >}}  {{< br >}}Final Comments and Course Evaluation